×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Measuring the effectiveness of risk minimisation measures
Session Chair(s)
Patrick Batty
Medicines and Healthcare Products Regulatory Agency, United Kingdom
Assessing the effectiveness of risk minimisation measures after they are implemented is an important aspect of risk management. This session will cover the key principles of measuring for measuring RMM effectiveness, and provide an opportunity to discuss challenges faced and approaches to address these.
Speaker(s)
Catarina Isabel Antunes Martins
Novartis Pharma AG, Switzerland
Global RMP Group Head
Measuring effectiveness of risk minimisation measures
Patrick Batty
Medicines and Healthcare Products Regulatory Agency, United Kingdom
James Milligan
Seqirus UK Limited, United Kingdom
Vice President Pharmacovigilance and Risk Management
Joanne Treacy, MSc
JBTHealthSolutions, United Kingdom
Risk Management Consultant
Have an account?